F&G Annuities & Life Insider Bought Shares Worth $356,450, According to a Recent SEC Filing-March 2024-www.financetom.com

F&G Annuities & Life Insider Bought Shares Worth $356,450, According to a Recent SEC Filing

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

F&G Annuities & Life Insider Bought Shares Worth $356,450, According to a Recent SEC Filing

Mar 25, 2025 2:14 PM

04:40 PM EDT, 03/25/2025 (MT Newswires) -- Christopher O Blunt, Director, Chief Executive Officer, on March 25, 2025, executed a purchase for 10,000 shares in F&G Annuities & Life ( FG ) for $356,450. Following the Form 4 filing with the SEC, Blunt has control over a total of 839,584 common shares of the company, with 839,584 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1934850/000112760225010361/xslF345X05/form4.xml

Previous page： Google agrees $36 million fine for anti-competitive deals with Australia telcos Next page： Alnylam's Amvuttra Sales Exceeding Expectations by Sizable Margin, Oppenheimer Says

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Google agrees $36 million fine for anti-competitive deals with Australia telcos

Aug 17, 2025

SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...

Alnylam's Amvuttra Sales Exceeding Expectations by Sizable Margin, Oppenheimer Says

Aug 4, 2025

10:48 AM EDT, 08/04/2025 (MT Newswires) -- Alnylam Pharmaceuticals' ( ALNY ) Amvuttra saw about $150 million in first full-quarter sales to treat ATTR cardiomyopathy, which was above market expectations by a sizable margin, Oppenheimer said in a note to clients Monday. Alnylam obtained payer agreements much faster than expected, the investment firm said. Total sales of Amvuttra at $492...

Bullish Launches 20.3 Million Share IPO, Targeting $28-$31 Price Range

Aug 4, 2025

10:43 AM EDT, 08/04/2025 (MT Newswires) -- Bullish said Monday it has launched an initial public offering of 20.3 million ordinary shares, with an expected price between $28 and $31 apiece. The digital asset platform said it plans to grant underwriters a 30-day option to buy up to 3.05 million additional shares. Bullish said it has applied for the listing...

Live Nation Entertainment Seen Reiterating Positive Outlook, Oppenheimer Says

Aug 4, 2025

10:49 AM EDT, 08/04/2025 (MT Newswires) -- Live Nation Entertainment ( LYV ) is expected to reiterate its positive outlook for this year, Oppenheimer said Monday in an earnings preview. Earnings reports from other companies suggest that US consumer spending continues to be healthy, the report said. Oppenheimer cut its Q2 revenue estimates concerts by 1% and sponsorship segments by...